Why Sales Estimates for Dendreon's Provenge Are Too Low [View article]
>>Of the 230,000 new prostate cancer patients per year, roughly 80-85% of them will fail hormone therapy at some point.<<
That's nonsense. Roughly 80-85% of them never even begin hormone therapy (actually hormone DEPRIVATION therapy) because they are completely cured of their prostate cancer or die of something else before it becomes a problem.
Sort by:
Latest | Highest ratedWhy Sales Estimates for Dendreon's Provenge Are Too Low [View article]
That's nonsense. Roughly 80-85% of them never even begin hormone therapy (actually hormone DEPRIVATION therapy) because they are completely cured of their prostate cancer or die of something else before it becomes a problem.
Verenium: Green And Promising Emerging Biotechnologies [View article]